Extended adjuvant temozolomide in newly diagnosed glioblastoma: A single-center retrospective study

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 24,516 followers.

Extended adjuvant temozolomide in newly diagnosed glioblastoma: A single-center retrospective study https://t.co/wIIVpJoerz https://t.co/sEgeAU1aUU

11 Dec 2022

Reply Repost Favourite

Extended adjuvant temozolomide in newly diagnosed glioblastoma: A single-center retrospective study https://t.co/RYnTqCZfRl https://t.co/uvS6ZaiV5b

26 Nov 2022

Reply Repost Favourite

New research: Extended adjuvant temozolomide in newly diagnosed glioblastoma: A single-center retrospective study: Objective To investigate whether extending adjuvant temozolomide (TMZ) improved the prognosis of newly diagnosed glioblastoma… https://t.co/

22 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.